Thomas Van Dorpe

The business wants AI agents. The use cases look compelling. The technology is evolving faster than most organisations can comfortably track. Then someone from...

Most pharma AI initiatives do not fail because the technology does not work. They fail because no one can clearly answer a much more basic question: Who owns...

Pharma is in the middle of its biggest regulatory shift in more than 30 years. For the first time, regulators are explicitly addressing AI, with dedicated...

Model performance is no longer the primary bottleneck to AI adoption. The real challenge is connecting it to your business context and systems. The AI and...

The Fastest Tech Wave Ever Technology adoption has never moved this fast. Mobile phones took 16 years to reach 100 million users. The Internet needed seven....

What sets leading organizations apart today is their ability to transform data into immediate, meaningful action. In 2026, digital transformation is...

Imagine intelligent digital colleagues that work proactively and learn from user feedback; designed to automate repetitive tasks, reduce errors and give your...

The work doesn’t stop when a drug reaches the market. In fact, one of the most critical phases begins: monitoring patient safety. Pharmacovigilance is a...

Bringing a new drug to market is one of the most demanding challenges in the pharmaceutical industry. Clinical trials are essential, but they are long, costly,...

In pharmaceutical manufacturing, quality is everything. A single deviation can trigger a product recall, disrupt supply chains, and damage trust with patients...